Remove 2017 Remove Competition Remove Pharmaceutical research
article thumbnail

Pharmaceutical training boost: how the growth and skills levy could shape industry development

European Pharmaceutical Review

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the proposed changes, highlighting their potential to support talent development in areas such as advanced manufacturing, digital skills, and emerging biotechnologies. billion in 2017/18 to 2.5 billion in 2023/24.

article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Upcoming biosimilar competition for Humira means AbbVie’s focus may turn to Rinvoq, approved in the US for atopic dermatitis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis, and Skyrizi, approved in the US for psoriatic arthritis and plaque psoriasis. AbbVie reported a 22.7% Bristol Myers Squibb (BMS) documented a 9.1%

Sales 108
article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. However, they face increasing competition from foreign generic drug suppliers, which have established themselves in the market for public tenders.